Oral Vitamin D Supplementation Prevent Peritoneal Dialysis-related Peritonitis
Status:
Recruiting
Trial end date:
2026-05-31
Target enrollment:
Participant gender:
Summary
This is a multicenter randomized, placebo-controlled trial of Vitamin D supplementation in
patients on peritoneal dialysis to determine whether oral administration of vitamin D3 after
curing an episode of peritonitis could reduce the risk of subsequent peritoneal
dialysis-related peritonitis.
Phase:
Phase 4
Details
Lead Sponsor:
Peking University First Hospital
Collaborators:
Beijing Anzhen Hospital, Capital Medicine University Beijing Fangshan District Hospital of Traditional Chinese Medicine Beijing Haidian Hospital Beijing Luhe Hospital, Capital Medicine University Beijing Tsinghua Changgeng Hospital Miyun District of Peking University First Hospital Peking University International Hospital Peking University People's Hospital Peking University Shenzhen Hospital Peking University Third Hospital